The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,255.00
Bid: 2,220.00
Ask: 2,290.00
Change: -60.00 (-2.61%)
Spread: 70.00 (3.153%)
Open: 2,295.00
High: 2,240.00
Low: 2,240.00
Prev. Close: 2,300.00
CRW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

16 Nov 2023 07:00

RNS Number : 6203T
Craneware plc
16 November 2023
 

 

16 November 2023

 

Craneware plc

?

("Craneware" or the "Company" or the "Group")

 

AGM Statement

Craneware (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, is pleased to provide an update on trading ahead of its Annual General Meeting, which takes place at 10am today.  

 

The Group has enjoyed continued positive financial and operational performance since the start of the new financial year. The partner opportunities which launched at the end of the last financial year continue to gather momentum and the underlying sales pipeline continues to build, converting at an encouraging rate into revenue. With financial results tracking in line with management expectations, we look forward to providing a greater level of detail with our next Trading Update, ahead of our Interim Results.

 

US hospitals are now returning their attention to providing Value-Based Care and building resilience into their operating models through greater insights into their financials and operations. Through Trisus, our cloud-based data analytics and intelligence platform, we plan to be a central player in the digitalisation, the use of data to provide insights that improve the processes, of US healthcare. The team is focused on capturing this opportunity through market expansion and the delivery of increased value to our extensive hospital customer base.

 

We are confident that our resilient business model, extensive customer base, high levels of Annual Recurring Revenue, together with our strategy for delivering growth centred on the expansion of the Trisus platform, will enable us to create further long-term value for all our stakeholders.   

 

For further information, please contact:

 

 

Craneware plc

+44 (0)131 550 3100

Keith Neilson, CEO

Craig Preston, CFO

 

Alma (Financial PR)

+44 (0)20 3405 0205

Caroline Forde, Joe Pederzolli, Kinvara Verdon

craneware@almastrategic.com

 

Peel Hunt (NOMAD and Joint Broker) 

+44 (0)20 7418 8900

Neil Patel, Paul Gillam, Richard Chambers

 

Investec Bank PLC (Joint Broker)

+44 (0)20 7597 5970

Patrick Robb, Henry Reast, Cameron MacRitchie

  

Berenberg (Joint Broker)

+44 (0)20 3207 7800

Mark Whitmore, Richard Andrews, Dan Gee-Summons

 

 

About Craneware

 

The Craneware Group (AIM:CRW.L), the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group's Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care. Trisus combines revenue integrity, cost management, 340B performance, and decision enablement into a single, SaaS-based platform. Trisus Chargemaster secured top ranking in the Chargemaster Management category of the "2023 Best in KLAS Awards: Software & Services" and is part of an extensive value cycle management suite. The Craneware Group - transforming the business of healthcare.

 

Learn more at www.thecranewaregroup.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMDBBDBCXBDGXU
Date   Source Headline
27th Apr 201112:25 pmRNSBlocklisting Interim Review
27th Apr 201110:02 amRNSHolding(s) in Company
19th Apr 20115:28 pmRNSHolding(s) in Company
8th Apr 20114:18 pmRNSHolding(s) in Company
7th Apr 20114:49 pmRNSHolding(s) in Company
7th Apr 20113:52 pmRNSBlocklisting Application
7th Apr 20118:53 amRNSHolding(s) in Company
5th Apr 20112:11 pmRNSDirector Shareholding & Issue of Equity
1st Apr 20115:27 pmRNSAdditional Listing
31st Mar 20115:51 pmRNSTotal Voting Rights
25th Mar 20114:27 pmRNSHolding(s) in Company
25th Mar 20113:45 pmRNSDividend Currency Election
24th Mar 20117:00 amRNSAdditional Listing
17th Mar 20115:19 pmRNSDirector/PDMR Shareholding
15th Mar 201111:32 amRNSAdditional Listing
10th Mar 20115:27 pmRNSAdditional Listing
10th Mar 20115:22 pmRNSHolding(s) in Company
10th Mar 20115:18 pmRNSHolding(s) in Company
2nd Mar 20117:00 amRNSDirector & PDMR Shareholding
28th Feb 20114:31 pmRNSAdditional Listing
28th Feb 20113:46 pmRNSDirector/PDMR Shareholding
28th Feb 20117:00 amRNSHalf Yearly Report
18th Feb 20117:00 amRNSAcquisition of ClaimTrust
28th Jan 20118:26 amRNSHolding(s) in Company
25th Jan 20117:00 amRNSTrading Update & Notice of Results
21st Dec 20104:38 pmRNSAdviser - Change of Name
12th Nov 20108:19 amRNSDividend Currency Election
9th Nov 20102:34 pmRNSHolding(s) in Company
9th Nov 20102:22 pmRNSHolding(s) in Company
2nd Nov 20107:00 amRNSAGM Statement
19th Oct 20107:10 amRNSBlocklisting Interim Review
19th Oct 20107:00 amRNSPosting of Annual Report and Accounts
8th Oct 201012:44 pmRNSHolding(s) in Company
28th Sep 20107:00 amRNSContract Win for Supplies ChargeLink
22nd Sep 20107:00 amRNSHolding(s) in Company
9th Sep 20102:47 pmRNSDirector/PDMR Shareholding
8th Sep 20107:00 amRNSDirector/PDMR Shareholding
6th Sep 20107:00 amRNSFinal Results
10th Aug 20107:00 amRNSNotice of Final Results
14th Jul 20107:00 amRNSTrading Update
9th Jul 20107:00 amRNSLaunch of ADR Programme
22nd Apr 20104:08 pmRNSHolding(s) in Company-Amendment
22nd Apr 20102:27 pmRNSHolding(s) in Company
21st Apr 20103:41 pmRNSDirectors Shareholding
21st Apr 20107:00 amRNSReseller Agreement with Premier
15th Apr 20104:12 pmRNSBlocklisting Interim Review
5th Mar 201011:02 amRNSDividend Currency Election
22nd Feb 20107:01 amRNSContract Win
22nd Feb 20107:00 amRNSInterim Results
4th Feb 20105:17 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.